These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3512207)

  • 1. Continuous subcutaneous insulin infusion does not provoke significant acute-phase response.
    Sleightholm MA; Gallimore R; Tennent GA; Rowe IF; Kohner EM; Pepys MB
    Diabetes Care; 1986; 9(1):50-2. PubMed ID: 3512207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No sign of amyloidosis in pump-treated diabetics.
    Regal H; Koivisto VA; Maury CP; Irsigler K
    Diabetes Res; 1988 Aug; 8(4):195-9. PubMed ID: 3069282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion does not induce a significant acute phase response of serum amyloid A protein.
    Bending JJ; Pickup JC; Rowe IF; Gallimore R; Tennent G; Keen H; Pepys MB
    Diabetologia; 1985 Feb; 28(2):113-5. PubMed ID: 3979691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of insulin pump therapy with raised serum amyloid A in type I diabetes mellitus.
    Brownlee M; Vlassara H; Cerami A; Martin TR; Li JJ; McAdam KP
    Lancet; 1984 Feb; 1(8374):411-3. PubMed ID: 6142148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy.
    Scheinberg MA; Masuda A; Benson MD; Mendes NF
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):133-7. PubMed ID: 572349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence of amyloidosis in type I diabetics treated with continuous subcutaneous insulin infusion.
    Koivisto VA; Teppo AM; Maury CP; Taskinen MR
    Diabetes; 1983 Jan; 32(1):88-90. PubMed ID: 6848400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
    Attia N; Jones TW; Holcombe J; Tamborlane WV
    Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy.
    Connors LH; Gertz MA; Skinner M; Cohen AS
    J Lab Clin Med; 1984 Oct; 104(4):538-45. PubMed ID: 6090552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
    Kobayashi T; Sawano S; Itoh T; Kosaka K
    Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute phase response in bronchiectasis and bronchus carcinoma.
    Nel AE; Strachan AF; Welke HE; de Beer FC
    Respiration; 1985; 47(3):196-200. PubMed ID: 4001576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations.
    Rodger NW; Dupre J; Canny CL; Brown WF
    Diabetes Care; 1985; 8(5):447-55. PubMed ID: 3902423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
    Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous subcutaneous insulin infusion brings about normal blood sugar in type I diabetes mellitus despite relaxing of diet instructions].
    Sonnenberg GE; Chantelau E; Altenähr H; Berger M; Berchtold P
    Schweiz Med Wochenschr; 1982 Jan; 112(3):83-5. PubMed ID: 7036337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease.
    Raynes JG; Cooper EH
    J Clin Pathol; 1983 Jul; 36(7):798-803. PubMed ID: 6863571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis.
    de Beer FC; Nel AE; Gie RP; Donald PR; Strachan AF
    Thorax; 1984 Mar; 39(3):196-200. PubMed ID: 6710428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.